At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietar
BioTheranostics, a subsidiary of Hologic, Inc., is a leading provider of molecular-based diagnostic, prognostic, and predictive tests that empower physicians to deliver optimal care for cancer patients. As the organization’s hub for oncology, BioTheranostics, referred to as Oncology Services, is com
Get weekly curated job picks, salary trends, and career insights delivered to your inbox.